NIH Guide: Weekly Index for June 25, 2021

Funding Opportunities

• Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional)
  (PA-21-266)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 25, 2021. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
  (PAR-21-249)
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional)
  (PAR-21-250)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
  (PAR-21-275)
  National Institute on Minority Health and Health Disparities
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed)
  (RFA-AG-22-025)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2021
• Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
  (RFA-CA-21-026)
  National Cancer Institute
  Application Receipt Date(s): October 08, 2021
• Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-027)
  National Cancer Institute
  Application Receipt Date(s): October 08, 2021
• Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
  (RFA-CA-21-040)
  National Cancer Institute
  Application Receipt Date(s): November 1, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
• Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)
  (RFA-DA-22-003)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 02, 2022
• Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
  (RFA-DA-22-011)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 15, 2021
• NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional)
  (RFA-DC-22-001)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Multiple dates, see announcement.
• Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
  (RFA-DK-21-021)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 17, 2022 and October 7, 2022
• CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
  (RFA-ES-21-006)
  National Institute of Environmental Health Sciences
  National Institute of Allergy and Infectious Diseases
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required)
  (RFA-MH-21-240)
  National Institute of Mental Health
  Application Receipt Date(s): November 09, 2021
• Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)
  (RFA-MH-21-241)
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): November 09, 2021